Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
8.95
+0.01 (0.11%)
At close: Nov 22, 2024, 4:00 PM
9.18
+0.23 (2.57%)
After-hours: Nov 22, 2024, 4:05 PM EST
Corvus Pharmaceuticals Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for CRVS stock have an average target of 12.83, with a low estimate of 3.50 and a high estimate of 21. The average target predicts an increase of 43.35% from the current stock price of 8.95.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CRVS stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Reiterates $8 → $14 | Buy | Reiterates | $8 → $14 | +56.42% | Nov 13, 2024 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Maintains $12 → $21 | Strong Buy | Maintains | $12 → $21 | +134.64% | Sep 16, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $7 → $8 | Buy | Maintains | $7 → $8 | -10.61% | May 7, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Apr 1, 2024 |
| Mizuho | Mizuho | Hold Maintains $3.5 | Hold | Maintains | $3.5 | -60.89% | Mar 27, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
790.50K
EPS This Year
-0.43
from -0.56
EPS Next Year
-0.49
from -0.43
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 3.3M | 3.3M | ||
| Avg | n/a | 790,500 | 1.4M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 311.8% | ||
| Avg | - | - | 74.2% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.38 | -0.39 | -0.37 | ||
| Avg | -0.43 | -0.49 | -0.62 | ||
| Low | -0.47 | -0.57 | -0.81 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.